The fifth and final member of our OPERA 2025 shortlist, #WallisLau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use. Read the full profile here: buff.ly/unZtqxW The overall winner will be announced on Monday 30 June 2025 🏆

ADHD medication shortages are ongoing worldwide due to supply chain disruptions. If affected, speak with your healthcare provider about alternatives. Stay proactive for the best ADHD care! Read more: timespan.eu/adhd-medicat... By Andrew Yuen & @kennethkcman.bsky.social #ADHD #MedicationShortage

New study in @bmj.com! We find that gabapentinoid treatment not causally linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey.

🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth ➡ Full blog post: timespan.eu/healthcare-d...